J&J/McNeil Nicotrol comparative advertising claims challenged in SmithKline suit.
This article was originally published in The Tan Sheet
Executive Summary
J&J/McNEIL NICOTROL ADS ARE "DECEIVING," SMITHKLINE ALLEGES in a suit filed Dec. 4 in Manhattan federal court. NicoDerm CQ nicotine replacement therapy patch marketer SmithKline Beecham says it "seeks to stop [McNeil] from deceiving the public into thinking that [McNeil] has tests that prove that Nicotrol is more efficacious than Nicoderm CQ." A hearing is scheduled for Dec. 12 at 11:30 a.m. before Judge Barbara Jones. McNeil has not yet filed a response to SmithKline's complaint.